Does radiologically isolated syndrome mean I have MS?

Not by itself. RIS means the MRI shows lesions typical of MS in someone with no symptoms. Some people with RIS now meet the 2024 criteria for MS once the spinal fluid and follow-up scans are in; others do not, and are monitored. A specialist review sorts out which applies to you.

Can you have MS without symptoms?

Yes. The disease process can be visible on MRI years before it causes a symptom, and when MS-typical lesions are found by chance in someone who feels well, the finding is called radiologically isolated syndrome. Under the 2024 McDonald criteria, some people with RIS already meet the criteria for MS before any symptom: their lesions sit in typical places, and they also have new or enhancing lesions over time, abnormal spinal fluid, or the central vein sign on MRI. Others are monitored, because about half of people with RIS are still free of symptoms ten years later.

What are the chances RIS becomes MS?

About a third of people develop a first symptom within five years and about half within ten. A spinal cord lesion, abnormal spinal fluid, younger age, active lesions on a contrast scan, and new lesions on follow-up all raise the risk.

Should RIS be treated?

Sometimes. Two randomized trials showed that disease-modifying therapy delays a first attack in RIS. Treatment is favored when the risk features are present, and monitoring is reasonable when they are absent. It is a shared decision.

How often should I have an MRI with RIS?

A repeat brain MRI, often with the spinal cord, is usually done six to twelve months after the first, and then yearly if stable. The interval is shorter when there are risk features or new findings.

Are white matter spots on my MRI the same as RIS?

Usually not. Most white matter spots come from migraine, blood pressure, or age and sit in different places from MS lesions. RIS requires lesions that meet the MRI location criteria used for MS, which is why the images themselves need to be reviewed.

Radiologically Isolated Syndrome (RIS): What It Means

What radiologically isolated syndrome is

MRI scans are ordered for headaches, dizziness, head injuries, and sinus problems every day, and a small number of them show something the scan was not looking for: lesions in the white matter that have the size, shape, and location typical of multiple sclerosis, in a person who has never had a symptom of MS. That finding is called radiologically isolated syndrome, or RIS. About half of people with RIS are still free of symptoms ten years later. It was first defined in 2009, once MRI had become common enough for the situation to arise regularly.

RIS is not a diagnosis of MS, and it is not a reassurance either. It describes the earliest stage at which the disease process can be seen: demyelination is happening, but it has not yet touched a pathway that produces a symptom. The clinically isolated syndrome is the next stage, when a first symptom arrives. Which people move from one to the other, and how quickly, is now reasonably well understood.

A brain in cross-section with a few small highlighted ovals near the central fluid spaces, beside a sheet of paper and a pen. — RIS is defined by lesions in the places and shapes MS produces, not by white spots alone.

RIS or ordinary white spots?

Most white matter lesions on MRI are not MS and not RIS. Migraine, high blood pressure, diabetes, smoking, and age all produce small scattered spots, usually deep in the white matter and away from the ventricles. RIS requires lesions that meet the same MRI criteria for location used to diagnose MS: beside the ventricles, just under the cortex, in the brainstem or cerebellum, or in the spinal cord, with the oval shape and orientation MS produces. Many radiology reports use the phrase "nonspecific" for spots that do not meet that bar, and that word is doing real work. Reading the images directly, rather than relying on the report, is the first step in deciding which situation you are in.

The risk of developing MS

The long-term studies of RIS give consistent numbers. About a third of people have a first symptom within five years, and about half within ten. Several findings raise the risk, and they are the ones a specialist looks for:

A lesion in the spinal cord, the strongest single predictor.
Younger age, under about 37, at the time the scan was done.
Abnormal spinal fluid: oligoclonal bands or elevated kappa free light chains.
Enhancing lesions on a contrast scan, meaning active inflammation now.
New lesions on a follow-up scan.
Male sex, and a larger number of lesions.

The numbers behind those statements come from three cohorts:

Study	What it found
Multinational 10-year RIS cohort (Lebrun-Frénay et al., 2020), 451 people	The cumulative probability of a first clinical event at 10 years was 51.2%. Younger age, oligoclonal bands in spinal fluid, brainstem or cerebellar lesions, and spinal cord lesions were independent baseline predictors, and enhancing lesions during follow-up raised the risk further. The reason the MRI was ordered did not
Revised RIS criteria cohort (Lebrun-Frénay et al., 2023), 747 people	People with MS-typical lesions in only one or two of the characteristic locations had a 5-year event probability of 29%, against 38.7% for classic RIS. With a spinal cord lesion and oligoclonal bands, that lower-lesion group rose to 38%, the same as classic RIS
Early RIS cohort (Okuda et al., 2014)	About a third had a first symptom within five years, with younger age, male sex, and spinal cord lesions raising the risk

The 2024 McDonald criteria took the further step of allowing MS to be diagnosed in some people with RIS: when there are typical lesions in at least two of the five characteristic locations plus either new or enhancing lesions over time, abnormal spinal fluid, or a scan showing the central vein sign. For those people, the disease is considered established, and the question becomes treatment rather than monitoring.

How RIS is evaluated

A specialist review of RIS has a defined shape. The images themselves are reviewed, not just the report, to confirm the lesions are genuinely MS-typical. A careful history often turns up an episode years earlier, such as a few weeks of blurred vision or numbness, that was never evaluated and would change the label from RIS to a past attack. The examination looks for signs that never registered as symptoms. Then the workup is completed: MRI of the full spinal cord if it has not been done, a contrast brain scan, blood tests to exclude conditions that mimic MS, and usually a lumbar puncture, because the spinal fluid result changes both the risk estimate and, under the new criteria, possibly the diagnosis. The MS evaluation here plans all of it in one visit; the MRI is done at an outside imaging center and the lumbar puncture by an interventional radiologist at a partner facility.

Four questions cover most of it, and they are worth bringing to any appointment about an incidental finding. Are the lesions genuinely in the places and shapes MS produces? Has the spinal cord been imaged, and was it clear? Has spinal fluid been tested? And have I ever had an episode, however brief, that was never explained?

Monitoring and treatment

For years the only plan for RIS was to watch. Two randomized trials published in 2023 changed that: in people with RIS, dimethyl fumarate (the ARISE trial, 87 people) and teriflunomide (the TERIS trial, 89 people) lowered the chance of a first attack over about two years, by roughly 80% and 60% respectively, compared with placebo. Both trials were small, the MRI outcomes in TERIS did not reach significance, and neither answers who should be treated. What their placebo arms suggest is that waiting is not cost-free. Treatment before symptoms is therefore an option with evidence behind it, not a theoretical one.

It is not automatic. For someone with few lesions, a normal spinal cord, and normal spinal fluid, the risk is low enough that monitoring with a repeat MRI in six to twelve months is a sound plan. For someone with a spinal cord lesion, abnormal spinal fluid, or new lesions on follow-up, the case for starting a disease-modifying therapy is strong, and if the 2024 criteria are met the diagnosis is MS and treatment is standard care. In between, the decision is made together, with the numbers on the table.

Three empty film sleeves in a row, a notebook, a pen, and a small brain model on a desk. — Follow-up scans, spaced months apart, show whether the disease is active and whether the plan should change.

When to see a neurologist

See an MS specialist if an MRI report mentions demyelination, lesions "concerning for" or "in a pattern suggestive of" MS, or periventricular or juxtacortical lesions, even when you feel entirely well and even if a radiologist or another physician suggested simply repeating the scan in a year. Lesions found by chance, on a scan done for something else, can feel like a verdict; RIS is not a diagnosis of MS, and the review is not about alarm. It is about getting the risk estimate right and choosing a plan on purpose. If you have RIS, learn what a first attack looks like: blurred vision in one eye, numbness, weakness, or unsteadiness that builds over days and lasts more than 24 hours. Then call your neurologist the same day. Sudden weakness on one side, trouble speaking, or sudden vision loss can be a stroke: call 911. At our Multiple Sclerosis Clinic, Dr. Ntranos, a fellowship-trained MS specialist, reads your images with you scan by scan in a 60-minute first visit, usually available the same or next day, in person in Beverly Hills or Los Angeles, or by video anywhere in California. Bring or upload the actual images, not only the report, through our patient tools page. Follow-ups are usually every one to three months and last 30 to 45 minutes, and messages between visits are answered within 1 business day. Request a visit without a referral; the office confirms within 1 business day.

Radiologically Isolated Syndrome: MS-Like Lesions Found by Chance